BioSig Technologies, Inc. announced its intention to offer shares of common stock through a public offering.
The offering is underwritten and remains subject to market conditions.
The net proceeds will be used to purchase gold bullion, working capital, and general corporate purposes.
Proposed Public Offering
BioSig Technologies plans to offer shares of common stock through an underwritten public offering.
Use of Proceeds
The net proceeds will be used to purchase gold bullion, support working capital, and general corporate purposes.
Joint Book-Running Managers
Clear Street and Needham & Company are acting as joint book-running managers of the offering.
- The completion of the offering is subject to market conditions and timing uncertainties.
- Interested parties are advised to read the preliminary prospectus supplement and accompanying documents before investing.
BioSig Technologies' proposed public offering marks a strategic move in raising capital for the company's operations and investment policies.